Athersys shares rebound somewhat since falling by two-thirds on clinical trial results

Athersys plans to ask shareholders to approve a reverse stock split of its shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.